Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Blood (2019) 134 (Supplement_1): 5249.

https://doi.org/10.1182/blood-2019-125921

Published: 2019

Journal Articles

Retrospective Non-Interventional Assessment of the Use of Idelalisib in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Spain

Blood (2019) 134 (Supplement_1): 5473.

https://doi.org/10.1182/blood-2019-126588

Published: 2019

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

Juan Miguel Bergua, Pau Montesinos, MD, David Martinez-Cuadrón, MD, Pascual Fernández-Abellán, MD, Josefina Serrano, MD, María José Sayas, MD, Julio Prieto-Fernandez, MD, Raimundo Garcia, MD, Ana Julia Garcia-Huerta, MD, Manuel Barrios, MD, Cristina Pérez-López, MD, Manuel Perez-Encinas, MD, Adriana Siemele, MD, Gabriela Rodriguez-Macias, MD, Pilar Herrera-Puente, Rebeca Rodríguez-Veiga, MD, Maria Pilar Martinez-Sanchez, MD, Maria Lourdes Amador-Barciela, MD, Miguel A. Sanz, MD PhD

Blood (2014) 124 (21): 1049.

https://doi.org/10.1182/blood.V124.21.1049.1049

Published: 2014

Journal Articles

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Blood (2013) 122 (21): 3923.

https://doi.org/10.1182/blood.V122.21.3923.3923

Published: 2013

Journal Articles

Different Prognosis According to Subtype-Oriented Protocols in Elderly Patients with Acute Lymphoblastic Leukemia (ALL). Comparison of Three Prospective Parallel Trials from the Pethema Group

Blood (2013) 122 (21): 3869.

https://doi.org/10.1182/blood.V122.21.3869.3869

Published: 2013

Journal Articles

Minimal Residual Diease Evaluation By Flow Cytometry Is a Complementary Tool To Cytogenetics For Treatment Decision In Acute Myeloid Leukemia

Blood (2013) 122 (21): 2576.

https://doi.org/10.1182/blood.V122.21.2576.2576

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

Intensive (2+5) Or Semi-Intensive (FLUGA) Chemotherapy For Patients With Acute Myeloid Leukemia Who Are 70 Years Of Age Or Older

Blood (2013) 122 (21): 2687.

https://doi.org/10.1182/blood.V122.21.2687.2687

Published: 2013

Journal Articles

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Blood (2013) 122 (21): 1347.

https://doi.org/10.1182/blood.V122.21.1347.1347

Published: 2013

Journal Articles

Gene Microdeletions in Adult and Pediatric Acute Lymphoblastic Leukemia,

Blood (2011) 118 (21): 3539.

https://doi.org/10.1182/blood.V118.21.3539.3539

Published: 2011

Journal Articles

Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience

Pere Barba, Antonia Sampol, MD, María Calbacho, Jose Gonzalez, MD, Josefina Serrano, Pilar Martinez-Sanchez, MD, Pascual Fernandez, MD., Raimundo Garcia-Boyero, MD, Rodrigo Martino, MD, PhD, Pilar Delgado, MD, Jose Angel Hernandez-rivas, MD, Eloy Del Potro, MD, Soledad Gonzalez-Muñiz, MD, MAria Isabel Gomez-Sanchez, MD, Adolfo de la Fuente, MD, Javier Bueno, Josep-Maria Ribera, MD, PhD

Blood (2011) 118 (21): 4246.

https://doi.org/10.1182/blood.V118.21.4246.4246

Published: 2011

Journal Articles

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Blood (2009) 114 (1): 148–152.

https://doi.org/10.1182/blood-2008-11-187724

Published: 2009

Journal Articles

Comparable survival between HIV + and HIV − non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

Blood (2009) 113 (23): 6011–6014.

https://doi.org/10.1182/blood-2008-12-195388

Published: 2009

Journal Articles

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

Laura Rosiñol, José Antonio Pérez-Simón, Anna Sureda, Javier de la Rubia, Felipe de Arriba, Juan José Lahuerta, José David González, Joaquín Díaz-Mediavilla, Belén Hernández, Javier García-Frade, Dolores Carrera, Angel León, Miguel Hernández, Pascual Fernández Abellán, Juan Miguel Bergua, Jesús San Miguel, Joan Bladé

Blood (2008) 112 (9): 3591–3593.

https://doi.org/10.1182/blood-2008-02-141598

Published: 2008

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in HIV Associated Lymphoma (HIV-Ly) Patients: An Updated Analysis of the EBMT Lymphoma Working Party (EBMT-LWP) Experience.

Blood (2007) 110 (11): 1887.

https://doi.org/10.1182/blood.V110.11.1887.1887

Published: 2007

Journal Articles

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML): Report of 11 Cases.

Juan-Manuel Sancho, MD, Anne Parker, MD, Guillermo Deben, MD, Simon Bolam, MD, Eugenio Gimenez, MD, Eva Sanchez-Garcia, MD, Jose-Luis Piñana, MD, Teresa Pascual, MD, Carmen Mateos, MD, Pascual Fernandez-Abellan, MD, Luis Palomera, MD, Josep-Maria Ribera, PhD

Blood (2006) 108 (11): 4545.

https://doi.org/10.1182/blood.V108.11.4545.4545

Published: 2006

Journal Articles

Comparative Study of Autologous Stem Cell Transplant (ASCT) in HIV-1 Positive (HIV+) on Haart and HIV-1 Negative (HIV−) Non Hodgkin Lymphoma (NHL) Patients.

David Serrano, MD, Pascual Balsalobre, BN, Rafael Carrion, PhD,MD, Javier Anguita, MD, Pilar Miralles, MD, Juan Berenguer, PhD,MD, Ismael Buño, PhD, Alfonso Gomez-Pineda, MD, Rosario Varela, MD, Eulogio Conde, PhD,MD, Ildefonso Espigado, PhD,MD, Lourdes Escola, MD, Pascual Fernandez, MD, Pedro Sanchez-Godoy, PhD,MD, Javier Loscertales, MD, Josep-Maria Ribera, PhD,MD, Jose L. Diez-Martin, PhD,MD

Blood (2006) 108 (11): 3063.

https://doi.org/10.1182/blood.V108.11.3063.3063

Published: 2006

Journal Articles

Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.

Blood (2005) 106 (11): 2082.

https://doi.org/10.1182/blood.V106.11.2082.2082

Published: 2005

Journal Articles

Secondary Malignancies after Autologous Stem Cell Transplantation for Hodgkin’s Lymphoma: Incidence and Analysis of Risk Factors.

Blood (2004) 104 (11): 60.

https://doi.org/10.1182/blood.V104.11.60.60

Published: 2004

NARROW

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Retrospective Non-Interventional Assessment of the Use of Idelalisib in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Spain

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Different Prognosis According to Subtype-Oriented Protocols in Elderly Patients with Acute Lymphoblastic Leukemia (ALL). Comparison of Three Prospective Parallel Trials from the Pethema Group

Minimal Residual Diease Evaluation By Flow Cytometry Is a Complementary Tool To Cytogenetics For Treatment Decision In Acute Myeloid Leukemia

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Intensive (2+5) Or Semi-Intensive (FLUGA) Chemotherapy For Patients With Acute Myeloid Leukemia Who Are 70 Years Of Age Or Older

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Gene Microdeletions in Adult and Pediatric Acute Lymphoblastic Leukemia,

Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Comparable survival between HIV + and HIV − non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

Autologous Stem Cell Transplantation (ASCT) in HIV Associated Lymphoma (HIV-Ly) Patients: An Updated Analysis of the EBMT Lymphoma Working Party (EBMT-LWP) Experience.

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML): Report of 11 Cases.

Comparative Study of Autologous Stem Cell Transplant (ASCT) in HIV-1 Positive (HIV+) on Haart and HIV-1 Negative (HIV−) Non Hodgkin Lymphoma (NHL) Patients.

Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.

Secondary Malignancies after Autologous Stem Cell Transplantation for Hodgkin’s Lymphoma: Incidence and Analysis of Risk Factors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only